China Resources Pharmaceutical Group Limited (3320.HK)
HKD 4.9
(0.0%)
HKD 4.9
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 16.61 Billion HKD | 64.16% |
| 2022 | 10.12 Billion HKD | 40.95% |
| 2021 | 7.18 Billion HKD | 257.67% |
| 2020 | 2 Billion HKD | -78.28% |
| 2019 | 9.24 Billion HKD | -8.93% |
| 2018 | 10.14 Billion HKD | 194.74% |
| 2017 | 3.44 Billion HKD | -46.06% |
| 2016 | 6.38 Billion HKD | -50.44% |
| 2015 | 12.88 Billion HKD | -23.83% |
| 2014 | 16.91 Billion HKD | 53.0% |
| 2013 | 11.05 Billion HKD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 22.41 Billion HKD | 0.0% |
| 2023 FY | 16.61 Billion HKD | 64.16% |
| 2023 Q4 | 15.93 Billion HKD | 0.0% |
| 2023 Q2 | 12.45 Billion HKD | 0.0% |
| 2022 FY | 10.12 Billion HKD | 40.95% |
| 2022 Q2 | 11.57 Billion HKD | 0.0% |
| 2022 Q4 | 10.12 Billion HKD | 0.0% |
| 2021 Q4 | 7.18 Billion HKD | 0.0% |
| 2021 Q2 | 4.62 Billion HKD | 0.0% |
| 2021 FY | 7.18 Billion HKD | 257.67% |
| 2020 Q4 | 2 Billion HKD | 0.0% |
| 2020 Q2 | 6.64 Billion HKD | 0.0% |
| 2020 FY | 2 Billion HKD | -78.28% |
| 2019 Q4 | 9.24 Billion HKD | 0.0% |
| 2019 FY | 9.24 Billion HKD | -8.93% |
| 2019 Q2 | 11.56 Billion HKD | 0.0% |
| 2018 FY | 10.14 Billion HKD | 194.74% |
| 2018 Q4 | 10.14 Billion HKD | 0.0% |
| 2018 Q2 | 5.04 Billion HKD | 0.0% |
| 2017 Q4 | 3.44 Billion HKD | 0.0% |
| 2017 FY | 3.44 Billion HKD | -46.06% |
| 2017 Q2 | 3.41 Billion HKD | 0.0% |
| 2016 Q2 | 12.76 Billion HKD | 0.0% |
| 2016 Q4 | 6.38 Billion HKD | 0.0% |
| 2016 FY | 6.38 Billion HKD | -50.44% |
| 2015 FY | 12.88 Billion HKD | -23.83% |
| 2015 Q4 | 12.88 Billion HKD | 0.0% |
| 2014 FY | 16.91 Billion HKD | 53.0% |
| 2013 FY | 11.05 Billion HKD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 2.07 Million HKD | -801487.397% |
| Grand Pharmaceutical Group Limited | 990.02 Million HKD | -1578.427% |
| Extrawell Pharmaceutical Holdings Limited | 117.12 Million HKD | -14087.441% |
| Wai Yuen Tong Medicine Holdings Limited | 276.2 Million HKD | -5916.256% |
| Qianhai Health Holdings Limited | - HKD | -Infinity% |
| Lee's Pharmaceutical Holdings Limited | 70.63 Million HKD | -23424.688% |
| Essex Bio-Technology Limited | 36.05 Million HKD | -45985.432% |
| Tongfang Kontafarma Holdings Limited | 12.8 Million HKD | -129709.38% |
| PuraPharm Corporation Limited | 81.09 Million HKD | -20391.163% |
| SSY Group Limited | 1.94 Billion HKD | -753.213% |
| JBM (Healthcare) Limited | 43.8 Million HKD | -37838.125% |
| Jacobson Pharma Corporation Limited | 592.2 Million HKD | -2705.961% |